MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Essential tremor(ET)"

  • 2017 International Congress

    The effect of deep brain stimulation in a computational model of essential tremor

    N. Yousif, M. Mace, N. Pavese, S. Al-Rasheed, R. Borisyuk, P. Bain, D. Nandi (Hatfield, United Kingdom)

    Objective: This study aimed to better understand the mechanism underlying the pathological brain activity observed in essential tremor (ET) and the effect of thalamic deep…
  • 2017 International Congress

    Variability of spiral tremor during daily life of subjects with Essential Tremor

    J. Thompson-Westra, T. Wu, H. Cao, A. Pigg, G. Leodori, F.A. Vial Undurraga, M. Hallett, D. Haubenberger (Bethesda, MD, USA)

    Objective: To explore the long-term variability and reliability of tremor severity in Archimedes spirals in patients with Essential Tremor (ET). Background: ET affects activities of…
  • 2017 International Congress

    A Novel Deep Brain Stimulation Programming Paradigm for Essential Tremor

    J. Karl, L. Verhagen (Chicago, IL, USA)

    Objective: To report the outcome of a novel interleaving stimulation (interlink-ILS) DBS programming paradigm (PP). Background: DBS of the VIM is an effective treatment option…
  • 2017 International Congress

    Cortico-thalamic Biomarkers for a Responsive Deep Brain Stimulation: an enhanced Treatment of Essential Tremor.

    E. Opri, J. Shute, R. Molina, K. Foote, M. Okun, A. Gunduz (Gainesville, FL, USA)

    Objective: To explore cortico-thalamic biomarkers of intention tremor and intentional movement in hand Primary Motor (M1) and Premotor (PM) Cortex, and Ventral Intermediate Thalamic Nucleus…
  • 2017 International Congress

    Postoperative Cognitive Impairment Following Deep Brain Stimulation Surgery

    A. Whyte-Rayson, P. Hickey, M. Berger (Durham, NC, USA)

    Objective: To evaluate what intraoperative factors contribute to impairment after deep brain stimulation (DBS) surgery in patients with essential tremor (ET) and Parkinson’s disease (PD).…
  • 2017 International Congress

    Spectrum of non-motor symptoms in essential tremor in a Tunisian population

    M. Ben Djebara, I. Kacem, S. Mrabet, Y. Sidhom, B. Saguem, A. Nasri, A. Gargouri, R. Gouider (Manouba, Tunisia)

    Objective: Spectrum of non-motor symptoms in essential tremor in a Tunisian population Background: Several studies have recently lighted out the importance of NMS in ET.…
  • 2017 International Congress

    Whole exome sequencing in essential tremor.

    I. Alfradique-Dunham, L. Robak, A. Kaw, O. Fagbongbe, Z. Coban Akdemir, E. Young, J. Lupski, J. Jankovic, J. Shulman (Houston, TX, USA)

    Objective: Objective: To discover novel gene variants associated with essential tremor (ET) using whole exome sequencing (WES). Background: Background: ET, one of the most common…
  • 2017 International Congress

    Novel Programming Strategy to Overcome Loss of Efficacy in Essential Tremor

    S. Farris, M. Giroux (Englewood, CO, USA)

    Objective: A review of programming strategies to maintain tremor suppression adequate for functional satisfaction. Background: Deep brain stimulation (DBS) is FDA approved for Essential tremor since…
  • 2017 International Congress

    FXTAS, PD, and ET subjects demonstrate distinct gait, balance and tremor deficits under normal, environmentally challenging, and dual-task conditions

    E. Robertson, D. Hall, A. McAsey, M. Swanson, A. Bery, C. Huml, E. Berry-Kravis, J. O'Keefe (Chicago, IL, USA)

    Objective: To compare FXTAS, PD, ET and controls using quantitative measures of gait, balance, and tremor. Background: Fragile X-associated tremor/ataxia syndrome (FXTAS), a neurodegenerative disease…
  • 2017 International Congress

    Efficacy and safety of incobotulinumtoxinA (inco/A) for essential tremor using kinematics-guided clinical decision support: A randomized, double-blind, placebo-controlled trial

    M. Jog, J. Lee, M. Althaus, A. Scheschonka, H. Dersch, E.T. Study Team, D. Simpson (London, ON, Canada)

    Objective: To demonstrate improvement of arm tremor severity and hand function with kinematics-guided inco/A therapy Background: Botulinum neurotoxin A (BoNT-A) therapy of debilitating tremor symptoms…
  • « Previous Page
  • 1
  • …
  • 41
  • 42
  • 43
  • 44
  • 45
  • …
  • 50
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley